Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)
© Wang et al.; licensee BioMed Central Ltd. 2012
Received: 9 October 2011
Accepted: 27 August 2012
Published: 5 September 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|9 Oct 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|1 Jun 2012||Reviewed||Reviewer Report - Roberto Federico Villa|
|4 Jun 2012||Reviewed||Reviewer Report - Svetlana Lorenzano|
|15 Jun 2012||Reviewed||Reviewer Report - Daniele Tomassoni|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|26 Jul 2012||Author responded||Author comments - Penglian Wang|
|Resubmission - Version 4|
|26 Jul 2012||Submitted||Manuscript version 4|
|31 Jul 2012||Reviewed||Reviewer Report - Roberto Federico Villa|
|13 Aug 2012||Reviewed||Reviewer Report - Svetlana Lorenzano|
|Resubmission - Version 5|
|Submitted||Manuscript version 5|
|27 Aug 2012||Editorially accepted|
|5 Sep 2012||Article published||10.1186/1471-2377-12-88|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.